Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-10-11 |
| Court | District Court, D. Delaware | Date Terminated | 2022-10-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,010,533; 10,307,419; 6,562,375; 7,888,362; 8,008,006; 8,349,840; 8,618,109; 9,265,831; 9,572,796; 9,572,797; 9,839,637 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd.
Biologic Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Otsuka Pharmaceutical Co., Ltd. v. Zenara Pharma Private Ltd. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-07-27 | 126 | Opinion - Memorandum Opinion | one of the five patents-in-suit, U.S. Patent No. 10,307,419 (the '" 419 patent"). The parties…; It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification…;Plaintiffs") allege infringement of five patents against 18 pharmaceutical manufacturers seeking… Plaintiffs' REXULTI® tablets before the patents expire. (D.I. 71 ; D.I. 92 at 1) 1 REXULTI® is | External link to document |
| 2020-05-19 | 15 | Redacted Document | asserted U.S. Patent Nos. 9,265,831; 9,572,796; 9,572,797; and 10,010,533. Case…agree that Claim 1 of U.S. Patent No. 9,572,796 (“the ’796 patent”), shown below in relevant…from the patent disclosures is that a skilled artisan would understand the patents to disclose…on the Pleadings of Noninfringement of the '419 Patent by Biophore India Pharmaceuticals Private Ltd.,… Slayback Pharma LLC for infringing four patents covering Eagle’s brand name bendamustine | External link to document |
| 2019-10-11 | 4 | Patent/Trademark Report to Commissioner of Patents | ,349,840; 8,618,109; 9,839,637; 10,307,419. (nmg) (Entered: 10/15/2019) 11 October 2019 PACER … Otsuka Pharmaceutical Co., Ltd. 5 10,307,419 06/04/2019 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362; 8,349,840… or G Patents. ✔ ( G the patent action involves… PRIVATE LTD. PATENT OR DATE OF PATENT | External link to document |
| 2021-12-15 | 417 | Redacted Document | denying a motion for leave). 1 U.S. Patent Nos. 7,888,362; 8,349,840; 8,618,109; 9,839,637; and RE48,059…certification only as to the ’419 patent and not any of the other patents covering Otsuka’s Rexulti® product…Paragraph IV certifications for the patents in suit, including the ’419 patent, to Paragraph III certifications…SUMMARY JUDGMENT OF NONINFRINGEMENT OF THE ’419 PATENT {01752452;v1 } Case 1:19-cv-01938-LPS Document…expiration date of the other Orange Book listed patents.1 Specifically, Apotex provided notice of a Paragraph | External link to document |
| 2021-12-20 | 419 | Redacted Document | judgment of non-infringement of U.S. Patent No. 10,307,419 (“the ’419 patent”). Plaintiffs concede that there…of the ’419 Patent and Its Prosecution History The text of the ’419 patent and its prosecution… a plaintiff expressly narrowed a patent’s claims for patentability. Trading Techs. Int’l, Inc. v. Open… in one patent is presumed to inform the later use of that same limitation in related patents.” Trading… OF NON-INFRINGEMENT OF THE ’419 PATENT Case 1:19-cv-01938-LPS Document 419 Filed 12/20 | External link to document |
| 2021-02-18 | 49 | Claim Construction Chart | submit a joint chart for U.S. Patent No. 10,307,419 (“the ’419 patent”). Plaintiffs do not believe…Joint Exhibits J.E. 1 U.S. Patent No. 10,307,419 (BREX0000000210-224) J.E. 2 …constructions are necessary for the terms of the ’419 patent beyond their plain and ordinary meaning. … rely on extrinsic evidence. A copy of the ’419 patent and those portions of the intrinsic record relied… Issue “coating substantially ’419 patent, The phrase “coating Indefinite. | External link to document |
| 2022-09-21 | 575 | Order - -Memorandum and Order | opinions with respect to the patents-in-suit (U.S. Patent Nos. RE48,059, 8,349,840, 8,618,109, and 9,839,637…9,839,637; hereinafter, the “Brexpiprazole Patents”). (See D.I. 555 at 5) In their view, “a person of ordinary…b]efore the priority date of the Brexpiprazole Patents, Dr. Aubé was not a person of ordinary skill, …2019 26 October 2022 1:19-cv-01938 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
